Home  »  Business   »  What Do Analysts Say About bioAffinity Technologie...

What Do Analysts Say About bioAffinity Technologies Inc. (BIAF)?

bioAffinity Technologies Inc. (BIAF) saw an uptrend of 75.47% in the recent trading with $2.79 being its most recent. The current price level -82.06% lower than the highest price of $15.55 marked by the stock while trading over the past 52-weeks, whereas it is 112.98% higher than the lowest price of $1.31 the company dropped to over past 52-weeks. The latest news story on BIAF appeared in Business Wire under the title “bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research” on Jan-24-23.

Squeezing the time span to 30 day period shows us the stock is currently trading -30.08% below one month high and is +112.98% above of the lowest during that time. Looking into the simple moving average, bioAffinity Technologies Inc. (BIAF)’s stock stands at a SMA-50 of $2.1600 while that of 5-day is reading $1.8100.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

bioAffinity Technologies Inc. Earnings – What Happened With BIAF

Coming around sales and income figures on BIAF Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.

BIAF – bioAffinity Technologies Inc. Stock Earnings Estimates

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 8.37 million. BIAF does have institutional investors; and they hold 0.80% of the stock.

bioAffinity Technologies Inc. – Insider Activity and Holdings

Moreover, the latest SEC filings also revealed that stock came across 4 new insider purchases involving 32,576 shares. On the other hand, BIAF declared 0 shares have been sold in 0 insider transactions over the past three months.

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, bioAffinity Technologies Inc. has a debt to equity ratio of 0.06.

Technical Analysis of bioAffinity Technologies Inc. (NASDAQ:BIAF) stock

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free